世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

薬剤充填可能な塞栓用微小球の世界市場インサイト、2030年までの予測


Global Drug-Loadable Embolic Microspheres Market Insights, Forecast to 2030

薬剤装填可能な塞栓用マイクロスフェアは、腫瘍の血流と薬剤送達を遮断するために使用される治療用塞栓剤である。経動脈的化学塞栓療法(TACE)によって送達されるローダブル塞栓用マイクロスフェアは、腫瘍への... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2024年8月15日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

薬剤装填可能な塞栓用マイクロスフェアは、腫瘍の血流と薬剤送達を遮断するために使用される治療用塞栓剤である。経動脈的化学塞栓療法(TACE)によって送達されるローダブル塞栓用マイクロスフェアは、腫瘍への血流を止める治療用塞栓剤として、また薬物送達手段として機能する。
世界の薬剤ローダブル塞栓用マイクロスフェア市場は、2024年の100万米ドルから2030年には100万米ドルまで、予測期間中に年平均成長率(CAGR)%で成長すると予測されています。

薬剤装填型塞栓用マイクロスフェアの米国・カナダ市場は、2024年の百万米ドルから2030年には百万米ドルに達すると予測され、2024年から2030年の予測期間中に年平均成長率(CAGR)%で増加すると予測されています。
薬剤装填型塞栓用マイクロスフェアの中国市場は、2024年の100万ドルから2030年には100万ドルに達すると推定され、2024年から2030年の予測期間中のCAGRは%である。
薬剤装填可能な塞栓用ミクロスフェアのヨーロッパ市場は、2024年の百万ドルから2024年から2030年の予測期間中に年平均成長率%で増加し、2030年には百万ドルに達すると推定されています。
薬剤装填可能な塞栓用微小球の世界の主要メーカーは、ボストン・サイエンティフィック、テルモ、メリット・メディカル、バリアン、サーテックス・メディカル、蘇州恒瑞医療機器、ABKバイオメディカル、カーディオリンク・サイエンスなどである。2023年、世界の上位5社の売上高シェアは約 %であった。

レポートの内容
本レポートでは、薬剤充填可能な塞栓用マイクロスフェアの世界市場概要、売上、収益、価格を紹介しています。2019年~2023年の過去の市場収益/売上データ、2024年の予測、2030年までのCAGR予測による世界市場動向の分析。
本レポートでは、薬剤充填可能な塞栓用マイクロスフェアの主要生産者を調査し、主要地域・国の売上高も掲載しています。薬剤装填可能な塞栓用微小球の今後の市場ポテンシャルと、この市場を様々なセグメントとサブセグメントに予測するための主要地域/国の注目点のハイライト。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。

本レポートは、2019年から2024年までのデータで、薬剤装填可能な塞栓用マイクロスフェアの売上高、収益、市場シェア、主要メーカーの業界ランキングに焦点を当てています。世界の薬剤装填可能な塞栓用マイクロスフェア市場における主要な利害関係者を特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。
本レポートでは、2019年から2030年までのセグメントデータをタイプ別、用途別、売上高、収益、価格で分析しています。薬剤装填可能な塞栓用マイクロスフェアの販売、予測成長動向、生産技術、用途、エンドユーザー産業の評価と市場規模の予測。
ボストン・サイエンティフィック、テルモ、メリットメディカル、バリアン、サーテックス・メディカル、蘇州恒瑞医療器械、ABKバイオメディカル、カーディオリンク・サイエンスなど、世界の主要企業の詳細な企業プロフィール。

市場セグメンテーション
企業別
ボストン・サイエンティフィック
テルモ
メリットメディカル
バリアン
サーテックスメディカル
蘇州恒瑞医療機器
ABKバイオメディカル
カーディオリンクサイエンス
タイプ別セグメント
薬剤溶出性マイクロスフェア
放射性微小球
用途別セグメント
原発性肝がん
大腸がん肝転移
その他
地域別セグメント
米国およびカナダ
米国
カナダ
中国
アジア(中国を除く)
日本
韓国
中国 台湾
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東、アフリカ、中南米
ブラジル
メキシコ
トルコ
イスラエル
GCC諸国

各章の概要
第1章:報告書のスコープ、各市場セグメント(タイプ別、用途別など)の市場規模、今後の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性について、ハイレベルな見解を提供しています。
第2章 薬剤充填可能な塞栓用マイクロスフェアの世界、地域レベル、国レベルでの販売(消費)、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、生産能力などを紹介しています。
第3章:薬剤充填可能な塞栓用マイクロスフェアメーカーの競争環境、価格、売上高、市場シェア、業界ランキング、最新の開発計画、合併・買収情報などを詳細に分析。
第4章:タイプ別に様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。
第5章:読者が異なる下流市場のブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーする、アプリケーション別の様々な市場セグメントの分析を提供します。
第6章 北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の売上高、収益。
第7章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高、収益。
第8章:中国:タイプ別、用途別、セグメント別の売上高、収益。
第9章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別の売上高、収益。
第10章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別の売上高、収益。
第11章:主要メーカーのプロフィールを提供し、製品の説明と仕様、薬剤負荷可能な塞栓用マイクロスフェアの売上高、収益、価格、粗利益率、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介する。
第12章:産業チェーン、販売チャネル、主要原材料、流通業者と顧客の分析。
第13章:市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介します。
第14章:レポートの要点と結論。



ページTOPに戻る


目次

1 Study Coverage
1.1 Drug-Loadable Embolic Microspheres Product Introduction
1.2 Market by Type
1.2.1 Global Drug-Loadable Embolic Microspheres Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Drug-eluting Microspheres
1.2.3 Radioactive Microspheres
1.3 Market by Application
1.3.1 Global Drug-Loadable Embolic Microspheres Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Primary Liver Cancer
1.3.3 Colorectal Cancer Liver Metastasis
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Drug-Loadable Embolic Microspheres Revenue Estimates and Forecasts 2019-2030
2.2 Global Drug-Loadable Embolic Microspheres Revenue by Region
2.2.1 Global Drug-Loadable Embolic Microspheres Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Drug-Loadable Embolic Microspheres Revenue by Region (2019-2024)
2.2.3 Global Drug-Loadable Embolic Microspheres Revenue by Region (2025-2030)
2.2.4 Global Drug-Loadable Embolic Microspheres Revenue Market Share by Region (2019-2030)
2.3 Global Drug-Loadable Embolic Microspheres Sales Estimates and Forecasts 2019-2030
2.4 Global Drug-Loadable Embolic Microspheres Sales by Region
2.4.1 Global Drug-Loadable Embolic Microspheres Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Drug-Loadable Embolic Microspheres Sales by Region (2019-2024)
2.4.3 Global Drug-Loadable Embolic Microspheres Sales by Region (2025-2030)
2.4.4 Global Drug-Loadable Embolic Microspheres Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Drug-Loadable Embolic Microspheres Sales by Manufacturers
3.1.1 Global Drug-Loadable Embolic Microspheres Sales by Manufacturers (2019-2024)
3.1.2 Global Drug-Loadable Embolic Microspheres Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drug-Loadable Embolic Microspheres in 2023
3.2 Global Drug-Loadable Embolic Microspheres Revenue by Manufacturers
3.2.1 Global Drug-Loadable Embolic Microspheres Revenue by Manufacturers (2019-2024)
3.2.2 Global Drug-Loadable Embolic Microspheres Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Drug-Loadable Embolic Microspheres Revenue in 2023
3.3 Global Key Players of Drug-Loadable Embolic Microspheres, Industry Ranking, 2021 VS 2022
3.4 Global Drug-Loadable Embolic Microspheres Sales Price by Manufacturers (2019-2024)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Drug-Loadable Embolic Microspheres Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Drug-Loadable Embolic Microspheres, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Drug-Loadable Embolic Microspheres, Product Offered and Application
3.8 Global Key Manufacturers of Drug-Loadable Embolic Microspheres, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drug-Loadable Embolic Microspheres Sales by Type
4.1.1 Global Drug-Loadable Embolic Microspheres Historical Sales by Type (2019-2024)
4.1.2 Global Drug-Loadable Embolic Microspheres Forecasted Sales by Type (2025-2030)
4.1.3 Global Drug-Loadable Embolic Microspheres Sales Market Share by Type (2019-2030)
4.2 Global Drug-Loadable Embolic Microspheres Revenue by Type
4.2.1 Global Drug-Loadable Embolic Microspheres Historical Revenue by Type (2019-2024)
4.2.2 Global Drug-Loadable Embolic Microspheres Forecasted Revenue by Type (2025-2030)
4.2.3 Global Drug-Loadable Embolic Microspheres Revenue Market Share by Type (2019-2030)
4.3 Global Drug-Loadable Embolic Microspheres Price by Type
4.3.1 Global Drug-Loadable Embolic Microspheres Price by Type (2019-2024)
4.3.2 Global Drug-Loadable Embolic Microspheres Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Drug-Loadable Embolic Microspheres Sales by Application
5.1.1 Global Drug-Loadable Embolic Microspheres Historical Sales by Application (2019-2024)
5.1.2 Global Drug-Loadable Embolic Microspheres Forecasted Sales by Application (2025-2030)
5.1.3 Global Drug-Loadable Embolic Microspheres Sales Market Share by Application (2019-2030)
5.2 Global Drug-Loadable Embolic Microspheres Revenue by Application
5.2.1 Global Drug-Loadable Embolic Microspheres Historical Revenue by Application (2019-2024)
5.2.2 Global Drug-Loadable Embolic Microspheres Forecasted Revenue by Application (2025-2030)
5.2.3 Global Drug-Loadable Embolic Microspheres Revenue Market Share by Application (2019-2030)
5.3 Global Drug-Loadable Embolic Microspheres Price by Application
5.3.1 Global Drug-Loadable Embolic Microspheres Price by Application (2019-2024)
5.3.2 Global Drug-Loadable Embolic Microspheres Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Drug-Loadable Embolic Microspheres Market Size by Type
6.1.1 US & Canada Drug-Loadable Embolic Microspheres Sales by Type (2019-2030)
6.1.2 US & Canada Drug-Loadable Embolic Microspheres Revenue by Type (2019-2030)
6.2 US & Canada Drug-Loadable Embolic Microspheres Market Size by Application
6.2.1 US & Canada Drug-Loadable Embolic Microspheres Sales by Application (2019-2030)
6.2.2 US & Canada Drug-Loadable Embolic Microspheres Revenue by Application (2019-2030)
6.3 US & Canada Drug-Loadable Embolic Microspheres Market Size by Country
6.3.1 US & Canada Drug-Loadable Embolic Microspheres Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Drug-Loadable Embolic Microspheres Revenue by Country (2019-2030)
6.3.3 US & Canada Drug-Loadable Embolic Microspheres Sales by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Drug-Loadable Embolic Microspheres Market Size by Type
7.1.1 Europe Drug-Loadable Embolic Microspheres Sales by Type (2019-2030)
7.1.2 Europe Drug-Loadable Embolic Microspheres Revenue by Type (2019-2030)
7.2 Europe Drug-Loadable Embolic Microspheres Market Size by Application
7.2.1 Europe Drug-Loadable Embolic Microspheres Sales by Application (2019-2030)
7.2.2 Europe Drug-Loadable Embolic Microspheres Revenue by Application (2019-2030)
7.3 Europe Drug-Loadable Embolic Microspheres Market Size by Country
7.3.1 Europe Drug-Loadable Embolic Microspheres Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Drug-Loadable Embolic Microspheres Revenue by Country (2019-2030)
7.3.3 Europe Drug-Loadable Embolic Microspheres Sales by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Drug-Loadable Embolic Microspheres Market Size by Type
8.1.1 China Drug-Loadable Embolic Microspheres Sales by Type (2019-2030)
8.1.2 China Drug-Loadable Embolic Microspheres Revenue by Type (2019-2030)
8.2 China Drug-Loadable Embolic Microspheres Market Size by Application
8.2.1 China Drug-Loadable Embolic Microspheres Sales by Application (2019-2030)
8.2.2 China Drug-Loadable Embolic Microspheres Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Drug-Loadable Embolic Microspheres Market Size by Type
9.1.1 Asia Drug-Loadable Embolic Microspheres Sales by Type (2019-2030)
9.1.2 Asia Drug-Loadable Embolic Microspheres Revenue by Type (2019-2030)
9.2 Asia Drug-Loadable Embolic Microspheres Market Size by Application
9.2.1 Asia Drug-Loadable Embolic Microspheres Sales by Application (2019-2030)
9.2.2 Asia Drug-Loadable Embolic Microspheres Revenue by Application (2019-2030)
9.3 Asia Drug-Loadable Embolic Microspheres Market Size by Region
9.3.1 Asia Drug-Loadable Embolic Microspheres Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Drug-Loadable Embolic Microspheres Revenue by Region (2019-2030)
9.3.3 Asia Drug-Loadable Embolic Microspheres Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Drug-Loadable Embolic Microspheres Market Size by Type
10.1.1 Middle East, Africa and Latin America Drug-Loadable Embolic Microspheres Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Drug-Loadable Embolic Microspheres Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Drug-Loadable Embolic Microspheres Market Size by Application
10.2.1 Middle East, Africa and Latin America Drug-Loadable Embolic Microspheres Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Drug-Loadable Embolic Microspheres Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Drug-Loadable Embolic Microspheres Market Size by Country
10.3.1 Middle East, Africa and Latin America Drug-Loadable Embolic Microspheres Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Drug-Loadable Embolic Microspheres Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Drug-Loadable Embolic Microspheres Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 Boston Scientific
11.1.1 Boston Scientific Company Information
11.1.2 Boston Scientific Overview
11.1.3 Boston Scientific Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Boston Scientific Drug-Loadable Embolic Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Boston Scientific Recent Developments
11.2 Terumo
11.2.1 Terumo Company Information
11.2.2 Terumo Overview
11.2.3 Terumo Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Terumo Drug-Loadable Embolic Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Terumo Recent Developments
11.3 Merit Medical
11.3.1 Merit Medical Company Information
11.3.2 Merit Medical Overview
11.3.3 Merit Medical Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Merit Medical Drug-Loadable Embolic Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merit Medical Recent Developments
11.4 Varian
11.4.1 Varian Company Information
11.4.2 Varian Overview
11.4.3 Varian Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Varian Drug-Loadable Embolic Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Varian Recent Developments
11.5 Sirtex Medical
11.5.1 Sirtex Medical Company Information
11.5.2 Sirtex Medical Overview
11.5.3 Sirtex Medical Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Sirtex Medical Drug-Loadable Embolic Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sirtex Medical Recent Developments
11.6 Suzhou Hengrui Medical Equipment
11.6.1 Suzhou Hengrui Medical Equipment Company Information
11.6.2 Suzhou Hengrui Medical Equipment Overview
11.6.3 Suzhou Hengrui Medical Equipment Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Suzhou Hengrui Medical Equipment Drug-Loadable Embolic Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Suzhou Hengrui Medical Equipment Recent Developments
11.7 ABK Biomedical
11.7.1 ABK Biomedical Company Information
11.7.2 ABK Biomedical Overview
11.7.3 ABK Biomedical Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 ABK Biomedical Drug-Loadable Embolic Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 ABK Biomedical Recent Developments
11.8 Cardiolink Science
11.8.1 Cardiolink Science Company Information
11.8.2 Cardiolink Science Overview
11.8.3 Cardiolink Science Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Cardiolink Science Drug-Loadable Embolic Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Cardiolink Science Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Drug-Loadable Embolic Microspheres Industry Chain Analysis
12.2 Drug-Loadable Embolic Microspheres Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drug-Loadable Embolic Microspheres Production Mode & Process
12.4 Drug-Loadable Embolic Microspheres Sales and Marketing
12.4.1 Drug-Loadable Embolic Microspheres Sales Channels
12.4.2 Drug-Loadable Embolic Microspheres Distributors
12.5 Drug-Loadable Embolic Microspheres Customers
13 Drug-Loadable Embolic Microspheres Market Dynamics
13.1 Drug-Loadable Embolic Microspheres Industry Trends
13.2 Drug-Loadable Embolic Microspheres Market Drivers
13.3 Drug-Loadable Embolic Microspheres Market Challenges
13.4 Drug-Loadable Embolic Microspheres Market Restraints
14 Key Findings in the Global Drug-Loadable Embolic Microspheres Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Drug-loadable embolic microsphere is a therapeutic embolic agent used to block tumor blood flow and drug delivery. Loadable embolic microspheres delivered by transarterial chemoembolization (TACE) serve as a therapeutic embolic to stop blood flow to tumors and a drug delivery vehicle.
The global Drug-Loadable Embolic Microspheres market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.

The US & Canada market for Drug-Loadable Embolic Microspheres is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Drug-Loadable Embolic Microspheres is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Drug-Loadable Embolic Microspheres is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Drug-Loadable Embolic Microspheres include Boston Scientific, Terumo, Merit Medical, Varian, Sirtex Medical, Suzhou Hengrui Medical Equipment, ABK Biomedical, Cardiolink Science, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Includes
This report presents an overview of global market for Drug-Loadable Embolic Microspheres, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Drug-Loadable Embolic Microspheres, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Drug-Loadable Embolic Microspheres, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug-Loadable Embolic Microspheres sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Drug-Loadable Embolic Microspheres market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Drug-Loadable Embolic Microspheres sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Boston Scientific, Terumo, Merit Medical, Varian, Sirtex Medical, Suzhou Hengrui Medical Equipment, ABK Biomedical, Cardiolink Science, etc.

Market Segmentation
By Company
Boston Scientific
Terumo
Merit Medical
Varian
Sirtex Medical
Suzhou Hengrui Medical Equipment
ABK Biomedical
Cardiolink Science
Segment by Type
Drug-eluting Microspheres
Radioactive Microspheres
Segment by Application
Primary Liver Cancer
Colorectal Cancer Liver Metastasis
Others
Segment by region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Australia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Drug-Loadable Embolic Microspheres in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Drug-Loadable Embolic Microspheres manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug-Loadable Embolic Microspheres sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Drug-Loadable Embolic Microspheres Product Introduction
1.2 Market by Type
1.2.1 Global Drug-Loadable Embolic Microspheres Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Drug-eluting Microspheres
1.2.3 Radioactive Microspheres
1.3 Market by Application
1.3.1 Global Drug-Loadable Embolic Microspheres Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Primary Liver Cancer
1.3.3 Colorectal Cancer Liver Metastasis
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Drug-Loadable Embolic Microspheres Revenue Estimates and Forecasts 2019-2030
2.2 Global Drug-Loadable Embolic Microspheres Revenue by Region
2.2.1 Global Drug-Loadable Embolic Microspheres Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Drug-Loadable Embolic Microspheres Revenue by Region (2019-2024)
2.2.3 Global Drug-Loadable Embolic Microspheres Revenue by Region (2025-2030)
2.2.4 Global Drug-Loadable Embolic Microspheres Revenue Market Share by Region (2019-2030)
2.3 Global Drug-Loadable Embolic Microspheres Sales Estimates and Forecasts 2019-2030
2.4 Global Drug-Loadable Embolic Microspheres Sales by Region
2.4.1 Global Drug-Loadable Embolic Microspheres Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Drug-Loadable Embolic Microspheres Sales by Region (2019-2024)
2.4.3 Global Drug-Loadable Embolic Microspheres Sales by Region (2025-2030)
2.4.4 Global Drug-Loadable Embolic Microspheres Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Drug-Loadable Embolic Microspheres Sales by Manufacturers
3.1.1 Global Drug-Loadable Embolic Microspheres Sales by Manufacturers (2019-2024)
3.1.2 Global Drug-Loadable Embolic Microspheres Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drug-Loadable Embolic Microspheres in 2023
3.2 Global Drug-Loadable Embolic Microspheres Revenue by Manufacturers
3.2.1 Global Drug-Loadable Embolic Microspheres Revenue by Manufacturers (2019-2024)
3.2.2 Global Drug-Loadable Embolic Microspheres Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Drug-Loadable Embolic Microspheres Revenue in 2023
3.3 Global Key Players of Drug-Loadable Embolic Microspheres, Industry Ranking, 2021 VS 2022
3.4 Global Drug-Loadable Embolic Microspheres Sales Price by Manufacturers (2019-2024)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Drug-Loadable Embolic Microspheres Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Drug-Loadable Embolic Microspheres, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Drug-Loadable Embolic Microspheres, Product Offered and Application
3.8 Global Key Manufacturers of Drug-Loadable Embolic Microspheres, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drug-Loadable Embolic Microspheres Sales by Type
4.1.1 Global Drug-Loadable Embolic Microspheres Historical Sales by Type (2019-2024)
4.1.2 Global Drug-Loadable Embolic Microspheres Forecasted Sales by Type (2025-2030)
4.1.3 Global Drug-Loadable Embolic Microspheres Sales Market Share by Type (2019-2030)
4.2 Global Drug-Loadable Embolic Microspheres Revenue by Type
4.2.1 Global Drug-Loadable Embolic Microspheres Historical Revenue by Type (2019-2024)
4.2.2 Global Drug-Loadable Embolic Microspheres Forecasted Revenue by Type (2025-2030)
4.2.3 Global Drug-Loadable Embolic Microspheres Revenue Market Share by Type (2019-2030)
4.3 Global Drug-Loadable Embolic Microspheres Price by Type
4.3.1 Global Drug-Loadable Embolic Microspheres Price by Type (2019-2024)
4.3.2 Global Drug-Loadable Embolic Microspheres Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Drug-Loadable Embolic Microspheres Sales by Application
5.1.1 Global Drug-Loadable Embolic Microspheres Historical Sales by Application (2019-2024)
5.1.2 Global Drug-Loadable Embolic Microspheres Forecasted Sales by Application (2025-2030)
5.1.3 Global Drug-Loadable Embolic Microspheres Sales Market Share by Application (2019-2030)
5.2 Global Drug-Loadable Embolic Microspheres Revenue by Application
5.2.1 Global Drug-Loadable Embolic Microspheres Historical Revenue by Application (2019-2024)
5.2.2 Global Drug-Loadable Embolic Microspheres Forecasted Revenue by Application (2025-2030)
5.2.3 Global Drug-Loadable Embolic Microspheres Revenue Market Share by Application (2019-2030)
5.3 Global Drug-Loadable Embolic Microspheres Price by Application
5.3.1 Global Drug-Loadable Embolic Microspheres Price by Application (2019-2024)
5.3.2 Global Drug-Loadable Embolic Microspheres Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Drug-Loadable Embolic Microspheres Market Size by Type
6.1.1 US & Canada Drug-Loadable Embolic Microspheres Sales by Type (2019-2030)
6.1.2 US & Canada Drug-Loadable Embolic Microspheres Revenue by Type (2019-2030)
6.2 US & Canada Drug-Loadable Embolic Microspheres Market Size by Application
6.2.1 US & Canada Drug-Loadable Embolic Microspheres Sales by Application (2019-2030)
6.2.2 US & Canada Drug-Loadable Embolic Microspheres Revenue by Application (2019-2030)
6.3 US & Canada Drug-Loadable Embolic Microspheres Market Size by Country
6.3.1 US & Canada Drug-Loadable Embolic Microspheres Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Drug-Loadable Embolic Microspheres Revenue by Country (2019-2030)
6.3.3 US & Canada Drug-Loadable Embolic Microspheres Sales by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Drug-Loadable Embolic Microspheres Market Size by Type
7.1.1 Europe Drug-Loadable Embolic Microspheres Sales by Type (2019-2030)
7.1.2 Europe Drug-Loadable Embolic Microspheres Revenue by Type (2019-2030)
7.2 Europe Drug-Loadable Embolic Microspheres Market Size by Application
7.2.1 Europe Drug-Loadable Embolic Microspheres Sales by Application (2019-2030)
7.2.2 Europe Drug-Loadable Embolic Microspheres Revenue by Application (2019-2030)
7.3 Europe Drug-Loadable Embolic Microspheres Market Size by Country
7.3.1 Europe Drug-Loadable Embolic Microspheres Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Drug-Loadable Embolic Microspheres Revenue by Country (2019-2030)
7.3.3 Europe Drug-Loadable Embolic Microspheres Sales by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Drug-Loadable Embolic Microspheres Market Size by Type
8.1.1 China Drug-Loadable Embolic Microspheres Sales by Type (2019-2030)
8.1.2 China Drug-Loadable Embolic Microspheres Revenue by Type (2019-2030)
8.2 China Drug-Loadable Embolic Microspheres Market Size by Application
8.2.1 China Drug-Loadable Embolic Microspheres Sales by Application (2019-2030)
8.2.2 China Drug-Loadable Embolic Microspheres Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Drug-Loadable Embolic Microspheres Market Size by Type
9.1.1 Asia Drug-Loadable Embolic Microspheres Sales by Type (2019-2030)
9.1.2 Asia Drug-Loadable Embolic Microspheres Revenue by Type (2019-2030)
9.2 Asia Drug-Loadable Embolic Microspheres Market Size by Application
9.2.1 Asia Drug-Loadable Embolic Microspheres Sales by Application (2019-2030)
9.2.2 Asia Drug-Loadable Embolic Microspheres Revenue by Application (2019-2030)
9.3 Asia Drug-Loadable Embolic Microspheres Market Size by Region
9.3.1 Asia Drug-Loadable Embolic Microspheres Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Drug-Loadable Embolic Microspheres Revenue by Region (2019-2030)
9.3.3 Asia Drug-Loadable Embolic Microspheres Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Drug-Loadable Embolic Microspheres Market Size by Type
10.1.1 Middle East, Africa and Latin America Drug-Loadable Embolic Microspheres Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Drug-Loadable Embolic Microspheres Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Drug-Loadable Embolic Microspheres Market Size by Application
10.2.1 Middle East, Africa and Latin America Drug-Loadable Embolic Microspheres Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Drug-Loadable Embolic Microspheres Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Drug-Loadable Embolic Microspheres Market Size by Country
10.3.1 Middle East, Africa and Latin America Drug-Loadable Embolic Microspheres Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Drug-Loadable Embolic Microspheres Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Drug-Loadable Embolic Microspheres Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 Boston Scientific
11.1.1 Boston Scientific Company Information
11.1.2 Boston Scientific Overview
11.1.3 Boston Scientific Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Boston Scientific Drug-Loadable Embolic Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Boston Scientific Recent Developments
11.2 Terumo
11.2.1 Terumo Company Information
11.2.2 Terumo Overview
11.2.3 Terumo Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Terumo Drug-Loadable Embolic Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Terumo Recent Developments
11.3 Merit Medical
11.3.1 Merit Medical Company Information
11.3.2 Merit Medical Overview
11.3.3 Merit Medical Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Merit Medical Drug-Loadable Embolic Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merit Medical Recent Developments
11.4 Varian
11.4.1 Varian Company Information
11.4.2 Varian Overview
11.4.3 Varian Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Varian Drug-Loadable Embolic Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Varian Recent Developments
11.5 Sirtex Medical
11.5.1 Sirtex Medical Company Information
11.5.2 Sirtex Medical Overview
11.5.3 Sirtex Medical Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Sirtex Medical Drug-Loadable Embolic Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sirtex Medical Recent Developments
11.6 Suzhou Hengrui Medical Equipment
11.6.1 Suzhou Hengrui Medical Equipment Company Information
11.6.2 Suzhou Hengrui Medical Equipment Overview
11.6.3 Suzhou Hengrui Medical Equipment Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Suzhou Hengrui Medical Equipment Drug-Loadable Embolic Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Suzhou Hengrui Medical Equipment Recent Developments
11.7 ABK Biomedical
11.7.1 ABK Biomedical Company Information
11.7.2 ABK Biomedical Overview
11.7.3 ABK Biomedical Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 ABK Biomedical Drug-Loadable Embolic Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 ABK Biomedical Recent Developments
11.8 Cardiolink Science
11.8.1 Cardiolink Science Company Information
11.8.2 Cardiolink Science Overview
11.8.3 Cardiolink Science Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Cardiolink Science Drug-Loadable Embolic Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Cardiolink Science Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Drug-Loadable Embolic Microspheres Industry Chain Analysis
12.2 Drug-Loadable Embolic Microspheres Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drug-Loadable Embolic Microspheres Production Mode & Process
12.4 Drug-Loadable Embolic Microspheres Sales and Marketing
12.4.1 Drug-Loadable Embolic Microspheres Sales Channels
12.4.2 Drug-Loadable Embolic Microspheres Distributors
12.5 Drug-Loadable Embolic Microspheres Customers
13 Drug-Loadable Embolic Microspheres Market Dynamics
13.1 Drug-Loadable Embolic Microspheres Industry Trends
13.2 Drug-Loadable Embolic Microspheres Market Drivers
13.3 Drug-Loadable Embolic Microspheres Market Challenges
13.4 Drug-Loadable Embolic Microspheres Market Restraints
14 Key Findings in the Global Drug-Loadable Embolic Microspheres Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(microspheres)の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る